Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2022

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth reconciliations of the numerators and denominators used to compute basic and diluted net loss per share of common stock attributable to NantHealth for the three and six months ended June 30, 2022 and 2021:

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
	Common Stock		Common Stock		Common Stock		Common Stock
Net loss per share numerator:
Net loss from continuing operations	$	(12,512)	$	(15,450)	$	(28,462)	$	(30,954)
Net loss attributable to noncontrolling interests	—		(128)				(219)
Net loss from continuing operations attributable to NantHealth	(12,512)		(15,322)		(28,462)		(30,735)
Income from discontinued operations attributable to NantHealth	—		19		—		24
Net loss attributable to NantHealth for basic and diluted net loss per share	$	(12,512)	$	(15,303)	$	(28,462)	$	(30,711)
Weighted-average shares for basic and diluted net loss per share	115,550,244		114,512,542		115,535,822		112,924,619
Basic and diluted net loss per share attributable to NantHealth:
Total net loss per share - common stock	$	(0.11)	$	(0.13)	$	(0.25)	$	(0.27)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following number of potential common shares at the end of each period were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive for the periods presented:

	June 30,
	2022	2021
Unvested and vested and unissued restricted stock units	119,705	119,705
Unexercised stock options	14,364,386	9,448,724
Convertible notes	35,732,853	36,515,562